๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Epimacular Brachytherapy for Neovascular Age-related Macular Degeneration (CABERNET)

โœ Scribed by Jackson, Timothy L.; Dugel, Pravin U.; Bebchuk, Judith D.; Smith, Kelly R.; Petrarca, Robert; Slakter, Jason S.; Jaffe, Glenn J.; Nau, Jeffrey A.

Book ID
123315554
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
137 KB
Volume
120
Category
Article
ISSN
0161-6420

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Neovascular Age-Related Macular Degenera
Neovascular Age-Related Macular Degeneration
โœ Veritti, Daniele; Sarao, Valentina; Lanzetta, Paolo ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› S. Karger AG ๐ŸŒ English โš– 187 KB
Neovascular Age-Related Macular Degenera
Neovascular Age-Related Macular Degeneration
โœ Aimee V. Chappelow, Dr Peter K. Kaiser ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Springer International Publishing AG ๐ŸŒ English โš– 150 KB
Ranibizumab for Neovascular Age-Related
Ranibizumab for Neovascular Age-Related Macular Degeneration
โœ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Massachusetts Medical Society ๐ŸŒ English โš– 299 KB

## Background: Ranibizumab--a recombinant, humanized, monoclonal antibody fab that neutralizes all active forms of vascular endothelial growth factor a--has been evaluated for the treatment of neovascular age-related macular degeneration. ## Methods: In this multicenter, 2-year, double-blind, sha